Symbol="MBRX"
AssetType="Common Stock"
Name="Moleculin Biotech Inc"
Description="Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant viruses and tumors in the United States. The company is headquartered in Houston, Texas."
CIK="1659617"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="16618300"
EBITDA="-31792000"
PERatio="None"
PEGRatio="0"
BookValue="1.543"
DividendPerShare="0"
DividendYield="0"
EPS="-1.06"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.307"
ReturnOnEquityTTM="-0.508"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.662"
EVToRevenue="-"
EVToEBITDA="0.393"
Beta="1.952"
num_52WeekHigh="1.94"
num_52WeekLow="0.518"
num_50DayMovingAverage="0.643"
num_200DayMovingAverage="1.002"
SharesOutstanding="29675500"
DividendDate="2021-02-01"
ExDividendDate="None"
symbol="MBRX"
open="0.58"
high="0.59"
low="0.55"
price="0.57"
volume="32113.00"
latest_trading_day="2023-07-07"
previous_close="0.57"
change="-0.00"
change_percent="-0.7520%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="96"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="4"
Volume_recent_avg="202741"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="96"
image_negative_thumbnail_id_1="1138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_negative_thumbnail_id_2="1095"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="600"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0108.jpeg"
image_positive_thumbnail_id_2="707"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0001.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
